Statera Biopharma Inc. Gains 616.67%
Thu, Jul 27, 2023 at 07:37 PM
Statera Biopharma Inc. (STAB:NASDAQ) jumped higher at $0.01, a gain of 616.7%. From Thu, Jul 13, 2023, the stock recorded 11.11% Up Days and 30.00% Green Days
The stock spiked on Mon, Feb 06, 2023 at $0.05 with a volume of 1M+.
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 616.67%
- Femasys Inc. (FEMY:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 105%
- UroGen Pharma Ltd. (URGN:NASDAQ), 98.56%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 90.38%
- Tupperware Brands Corporation (TUP:NYSE), 56.32%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Ultralife Corporation (ULBI:NASDAQ), 52.54%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 46%
- View Inc. (VIEW:NASDAQ), 44.36%